Given the observed increased risk of colorectal cancer among patients receiving GLP-1 receptor agonists, clinicians should approach long-term prescribing of these agents with careful consideration, particularly in individuals with additional risk factors for colorectal cancer, such as a family history, obesity, inflammatory bowel disease, or long-standing type 2 diabetes
Amin SP, Phelps RG, Goldberg DJ
When to stop taking semaglutide Someone should stop taking semaglutide when they have reached their weight loss goal and can maintain their new weight with a healthy lifestyle, said Bruno
These changes can significantly impact an individual's facial appearance and self-image
and BMI at baseline (3035, 3540, and 40 kg/m 2 )
$2+ BILLION IN RESULTS Ozempic vs